The javascript used on this site for creative design effects is not supported by your browser. Please note that this will not affect access to the content on this web site.
Skip Navigation
U.S. Department of Health and Human Services
  • YouTube
  • HRSA eNews
  • Print this
  • Email this

FY 2016 Manufacturer Audit Results

Updated 5/2/17. The results chart includes audits where the findings have been finalized. Remaining audits are still under review. Information on Corrective Action Plans and Sanctions will be updated once approved by HRSA. HRSA recommends covered entities do not contact audited manufacturers regarding sanctions until a corrective action plan has been approved by HRSA and posted on this website.

 

Manufacturer State OPA Findings Sanction Corrective Action Status Manufacturer Contact Information
Celgene NJ No adverse findings None N/A  
Valeant Pharmaceuticals, Inc. NJ No adverse findings None N/A  
Leading Pharma, LLC NJ No adverse findings None N/A  
Hospira, Inc. IL No adverse findings None N/A  
Fresenius Kabi IL No adverse findings None N/A